Delivery Order SPE2DR25D1017-SPE2DR26F9BMV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $1,052.96 and an ultimate completion date of October 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $10,020.70 and an ultimate completion date of January 8, 2026. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $52,650.50 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on October 20, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $5,160.55 and a completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on July 22, 2025, with a ceiling value of $5,160.55 and an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The vaccine delivery will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Varivax vaccine with diluents, valued at $1,019.65 with a completion date of December 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Varivax vaccine with diluents, with a contract ceiling value of $1,983.92 and a completion date of December 31, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement requirements through open competition. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on November 7, 2025, with a ceiling value of $1,998.92 and an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Varivax vaccine with diluents, valued at $7,297.92. This firm fixed-price delivery order is scheduled for completion by September 18, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the contractor's established capability to meet federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Varivax vaccine with diluents, valued at $3,967.80 with a firm fixed price structure. The contract is not set-aside and is scheduled for completion by January 7, 2026. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BMVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $5,951.70 and an ultimate completion date of January 8, 2026. This is a firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The vaccine will be delivered to the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies competitively. This delivery order reflects the company's ongoing role in supporting the Defense Health Agency and other government healthcare systems through the DLA's pharmaceutical supply chain, providing essential vaccines and medical commodities to meet military healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 12/15/25 |